Stay updated on Nivolumab with Cisplatin-RT in Head and Neck Cancers Clinical Trial
Sign up to get notified when there's something new on the Nivolumab with Cisplatin-RT in Head and Neck Cancers Clinical Trial page.

Latest updates to the Nivolumab with Cisplatin-RT in Head and Neck Cancers Clinical Trial page
- Check3 days agoChange DetectedA minor update to the ClinicalTrials.gov page’s technical revision/version indicator (from v3.5.2 to v3.5.3) is displayed.SummaryDifference0.1%

- Check10 days agoChange DetectedRevision history updated: v3.5.2 added and v3.5.0 removed.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedAdded related topic 'Squamous cell carcinoma of the head and neck' and a Genetic and Rare Diseases Information Center (GARD) resource.SummaryDifference0.2%

- Check39 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check46 days agoChange Detected- Page revision updated from v3.4.2 to v3.4.3. No substantive changes to study details or eligibility.SummaryDifference0.1%

- Check74 days agoChange DetectedAdded Revision: v3.4.2 to the page and removed the older government funding status notices (Revision: v3.4.1).SummaryDifference0.4%

Stay in the know with updates to Nivolumab with Cisplatin-RT in Head and Neck Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab with Cisplatin-RT in Head and Neck Cancers Clinical Trial page.